MedPath

Use of Fish Skin Graft (FSG) to Improve Wound Healing and Expedite Discharge at a County Safety-net Hospital

Not Applicable
Not yet recruiting
Conditions
Surgical Wound
Registration Number
NCT06910189
Lead Sponsor
The University of Texas Health Science Center, Houston
Brief Summary

The purpose of this study is to estimate the effect of FSG (Kerecis) on hospital length of stay among adult patients with surgical wounds of at least 40cm2 requiring surgical debridement

Detailed Description

Not available

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
96
Inclusion Criteria
  • Has wound greater than or equal to 40cm2 requiring surgical debridement
  • Agreeable to follow up period of up to 1 year
Exclusion Criteria
  • Patients with wounds that do not require surgical debridement.
  • Patients with a known allergy or other sensitivity to fish material
  • Patients who are deemed unlikely to follow up (e.g., patients who live out of state).
  • Patients in police custody/incarcerated.
  • Patients unable to communicate in either Spanish or English.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Hospital length of stayfrom time of admission to time of discharge (about 3 days from date of surgery)
Secondary Outcome Measures
NameTimeMethod
Number of participants that have recurrent surgical site infectionUpto 1 year after surgery
Number of participants that require reoperationUpto 1 year after surgery
Time to total wound healingFrom end of surgery to upto 1 year after surgery
Number of participants that need skin graftUpto 1 year after surgery
time from original surgery with placement of wound vac until the patient gets a skin graftupto 1 year after surgery
time to return to workFrom discharge (about 3 days from date of surgery) upto 1 year after surgery
Number of participants that need wound vac after dischargeAt discharge (about 3 days from date of surgery)
Inpatient hospital costsAt discharge (about 3 days from date of surgery)
financial toxicity experienced by patients as assessed by the COST - FACIT survey6 months after discharge

This is a 12 item questionnaire and each is scored from 0( not at all) to 4(very much), for a maximum score of 48, higher score indicating lower financial toxicity.

financial toxicity experienced by patients as assessed by the COmprehensive Score for financial Toxicity (COST)-Functional Assessment of Chronic Illness Therapy (FACIT) survey12 months after discharge

This is a 12 item questionnaire and each is scored from 0( not at all) to 4(very much). Questions 2,3,6 and 7 are reverse scored for a maximum score of 48, higher score indicating lower financial toxicity.

Trial Locations

Locations (1)

The University of Texas Health Science Center at Houston

🇺🇸

Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath